Patents
Patents and Intellectual Property
At Cosmo, our intellectual property rights constitute a critical asset underpinning our innovation and competitive advantage. We pursue a double-cover selective country patent strategy to maximize global protection for our proprietary technologies and products.
Our flagship MMX® platform technology patent has been filed and granted in virtually all major jurisdictions worldwide. Product-specific patents derived from this platform have also been filed and granted in most of these key markets. Additionally, where appropriate, we file process and use patents to further safeguard our innovations.
In accordance with 35 U.S.C. § 287(a), Cosmo provides detailed patent information for our products on this website, including relevant United States patents. We also provide information regarding European patents covering certain products. Each listed product is patented under, made under, or used under one or more of the patents referenced alongside the product name.
Please note that the patent information presented here is believed accurate as of the most recent update but is not exhaustive. The omission of a patent number from a product listing should not be construed as a representation that the product is unpatented or free of patent protection. Similarly, the absence of any product listing on this page does not imply that such product is unprotected by patent rights.
Cosmo endeavors to maintain reasonably current and accurate patent data on this website. However, some patents listed may have expired since the last update.
Patent information at your fingertips
For your convenience, you may explore the latest patent information in the sections below or review our current Financial Reports for additional disclosures.
Uceris®
(budesonide) extended release tablets, for oral use
United States Patents
United States Patents No. 8,895,064
United States Patents No. 9,132,093
United States Patents No. 9,192,581
United States Patents No. 10,307,375
United States Patents No. 10,660,858
EU Patents
Eleview®
Submucosal injectable composition 10 mL. To facilitate endoscopic resection procedures. 10 mL per ampoule.
United States Patents
United States Patents No. 9,226,996
United States Patents No. 9,364,580
United States Patents No. 9,522,216
United States Patents No. 9,962,445
United States Patents No. 9,987,366
United States Patents No. 10,413,611
United States Patents No. 10,849,979
United States Patents No. 12,337,002
EU Patents
EP2911707
EP3106182
Aemcolo®
(rifamycin) delayed-release tablets, for oral use
United States Patents
EU Patents
EP1763339
GI Genius™
(Cosmo Artificial Intelligence device for lesion detection during colonoscopy)
United States Patents
United States Patents No. 10,810,460
United States Patents No. 11,195,052
United States Patents No. 11,100,633
United States Patents No. 11,574,403
United States Patents No. 11,844,499
United States Patents No. 12,089,820
United States Patents No. 12,158,924
United States Patents No. 12,161,305
United States Patents No. 12,190,512
EU Patents
EP3762863
Winlevi®
United States Patents
United States Patents No. 9,211,295
United States Patents No. 8,143,240
United States Patents No. 8,865,690
United States Patents No. 10,159,682
United States Patents No. 9,486,458
United States Patents No. 9,433,628
United States Patents No. 8,785,427
United States Patents No. 11,207,332
United States Patents No. 11,938,141
United States Patents No. 10,116,245
United States Patents No. 10,716,796
United States Patents No. 12,337,002
EU Patents
EP2503004
EP2503005
EP2173891
EP2966175
Lumeblue®
United States Patents
EU Patents
EP2542268
EP3011975
EP2908866